Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial
(2015)
Journal Article
Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., & Millar, M. R. (2016). Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet, 387(10019), 649-660. https://doi.org/10.1016/s0140-6736%2815%2901027-2
© 2016 Elsevier Ltd. Summary Background Probiotics may reduce necrotising enterocolitis and late-onset sepsis after preterm birth. However, there has been concern about the rigour and generalisability of some trials and there is no agreement about wh... Read More about Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.